JP2016503403A5 - - Google Patents

Download PDF

Info

Publication number
JP2016503403A5
JP2016503403A5 JP2015540765A JP2015540765A JP2016503403A5 JP 2016503403 A5 JP2016503403 A5 JP 2016503403A5 JP 2015540765 A JP2015540765 A JP 2015540765A JP 2015540765 A JP2015540765 A JP 2015540765A JP 2016503403 A5 JP2016503403 A5 JP 2016503403A5
Authority
JP
Japan
Prior art keywords
alkyl
acceptable salt
pharmaceutically acceptable
compound
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015540765A
Other languages
English (en)
Japanese (ja)
Other versions
JP6372666B2 (ja
JP2016503403A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/067674 external-priority patent/WO2014070979A1/en
Publication of JP2016503403A publication Critical patent/JP2016503403A/ja
Publication of JP2016503403A5 publication Critical patent/JP2016503403A5/ja
Application granted granted Critical
Publication of JP6372666B2 publication Critical patent/JP6372666B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015540765A 2012-11-03 2013-10-31 サイトメガロウイルスの阻害剤 Active JP6372666B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261722152P 2012-11-03 2012-11-03
US61/722,152 2012-11-03
PCT/US2013/067674 WO2014070979A1 (en) 2012-11-03 2013-10-31 Inhibitors of cytomegalovirus

Publications (3)

Publication Number Publication Date
JP2016503403A JP2016503403A (ja) 2016-02-04
JP2016503403A5 true JP2016503403A5 (cg-RX-API-DMAC7.html) 2016-12-15
JP6372666B2 JP6372666B2 (ja) 2018-08-15

Family

ID=49620281

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015540765A Active JP6372666B2 (ja) 2012-11-03 2013-10-31 サイトメガロウイルスの阻害剤

Country Status (4)

Country Link
US (1) US9334249B2 (cg-RX-API-DMAC7.html)
EP (1) EP2914592B1 (cg-RX-API-DMAC7.html)
JP (1) JP6372666B2 (cg-RX-API-DMAC7.html)
WO (1) WO2014070979A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3805233T (pt) 2014-01-13 2024-04-15 Aurigene Oncology Ltd Enantiómeros (r) e (s) de n-(5-(3-hidroxipirrolidin-1-il)-2 morfolinooxazolo[4,5-b]piridin-6-il)-2-(2-metilpiridin-4-il)oxazole-carboxamida como inibidores de irak4 para o tratamento de cancro
CA3056893A1 (en) 2017-03-31 2018-10-04 Aurigene Discovery Technologies Limited Compounds and compositions for treating hematological disorders
RS65572B1 (sr) 2017-10-31 2024-06-28 Curis Inc Inhibitor irak4 u kombinaciji sa inhibitorom bcl-2 za upotrebu u lečenju kancera
AU2019339777B2 (en) 2018-09-12 2022-09-01 Novartis Ag Antiviral pyridopyrazinedione compounds
TWI867053B (zh) 2019-09-26 2024-12-21 瑞士商諾華公司 抗病毒吡唑并吡啶酮化合物
CN111763201A (zh) * 2020-03-03 2020-10-13 中国药科大学 苯并噻唑类化合物及医药用途
CN113831301B (zh) * 2020-06-08 2023-06-06 沈阳药科大学 苯并噻唑类衍生物及其用途
AU2021315786A1 (en) 2020-07-31 2023-02-23 Children's Healthcare Of Atlanta, Inc. Cystic fibrosis transmembrane conductance regulator (CFTR) modulators, pharmaceutical compositions, and uses thereof
US12178821B2 (en) 2021-04-08 2024-12-31 Curis, Inc. Combination therapies for the treatment of cancer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1137632E (pt) * 1998-12-09 2004-11-30 Wyeth Corp Tioureias inibidoras de virus herpes
ID30158A (id) * 1998-12-09 2001-11-08 American Home Prod Thiourea yang mengandung heterosiklik karboksamida, pencegah-pencegah virus-virus herpes yang mengandung gugus fenilenadiamina
JP2002533301A (ja) * 1998-12-09 2002-10-08 ワイス 置換フェニレンジアミン群を含む、複素環式カルボキサミド含有の、ヘルペスウイルスのチオ尿素インヒビター
US6166028A (en) 1998-12-09 2000-12-26 American Home Products Corporation Diaminopuridine-containing thiourea inhibitors of herpes viruses
BR0209054A (pt) * 2001-04-19 2004-04-20 Bayer Ag Arilsulfonamidas como agentes antivirais
CA2494942A1 (en) 2002-08-08 2004-02-19 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted benzimidazole compounds
US8101610B2 (en) 2005-11-14 2012-01-24 Genentech, Inc. Bisamide inhibitors of hedgehog signaling
WO2008031534A1 (en) * 2006-09-11 2008-03-20 Syngenta Participations Ag Insecticidal compounds
US20090069288A1 (en) * 2007-07-16 2009-03-12 Breinlinger Eric C Novel therapeutic compounds
WO2010029300A1 (en) 2008-09-12 2010-03-18 Biolipox Ab Bis aromatic compounds for use in the treatment of inflammation
EP2177521A1 (en) 2008-10-14 2010-04-21 Almirall, S.A. New 2-Amidothiadiazole Derivatives
AR077033A1 (es) * 2009-06-11 2011-07-27 Hoffmann La Roche Compuestos inhibidores de las quinasas de janus y su uso en el tratamiento de enfermedades inmunologicas

Similar Documents

Publication Publication Date Title
JP2016503403A5 (cg-RX-API-DMAC7.html)
JP2015536947A5 (cg-RX-API-DMAC7.html)
JP2016505614A5 (cg-RX-API-DMAC7.html)
JP2015500843A5 (cg-RX-API-DMAC7.html)
JP2013544860A5 (cg-RX-API-DMAC7.html)
JP2015537008A5 (cg-RX-API-DMAC7.html)
JP2012144574A5 (cg-RX-API-DMAC7.html)
JP2015512931A5 (cg-RX-API-DMAC7.html)
JP2018135343A5 (cg-RX-API-DMAC7.html)
JP2009263394A5 (cg-RX-API-DMAC7.html)
JP2013542218A5 (cg-RX-API-DMAC7.html)
JP2013510120A5 (cg-RX-API-DMAC7.html)
JP2011518833A5 (cg-RX-API-DMAC7.html)
JP2012092103A5 (cg-RX-API-DMAC7.html)
JP2013544276A5 (cg-RX-API-DMAC7.html)
JP2016503797A5 (cg-RX-API-DMAC7.html)
JP2014526533A5 (cg-RX-API-DMAC7.html)
JP2013534248A5 (cg-RX-API-DMAC7.html)
JP2016515560A5 (cg-RX-API-DMAC7.html)
JP2016510323A5 (cg-RX-API-DMAC7.html)
JP2011500550A5 (cg-RX-API-DMAC7.html)
JP2014521744A5 (cg-RX-API-DMAC7.html)
JP2011137045A5 (cg-RX-API-DMAC7.html)
JP2018533593A5 (cg-RX-API-DMAC7.html)
JP2013532687A5 (cg-RX-API-DMAC7.html)